World Health Organization - International Society of Hypertension Guidelines and the role of ongoing trials

G. Mancia, G. Grassi

Research output: Contribution to journalArticle

Abstract

Guidelines for non-pharmacological and pharmacological approaches to the treatment of hypertension were issued for the first time in the middle of the 1970s and were periodically updated in the following years. This paper will review the main features and elements of novelty of the World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension issued in 1999. After briefly describing data relating to the epidemiology of hypertension, the 1999 WHO-ISM Guidelines take into account the determinants of cardiovascular disease risk in hypertensive patients. Particular emphasis is placed on the contributions from and interactions between high blood pressure and other factors or conditions (diabetes, smoking, hypercholesterolaemia, alcohol consumption, overweight and obesity, etc) involved in determining the risk profile of individual patients. Finally, the WHO-ISM 1999 Guidelines provide recommendations for hypertension drug treatment in relation to the risk stratification and prognosis quantification, indicating the specific therapeutic strategy to be followed in each risk category.

Original languageEnglish
Pages (from-to)7-10
Number of pages4
JournalEuropean Heart Journal, Supplement
Volume2
Issue numberD
Publication statusPublished - 2000

Fingerprint

Guidelines
Hypertension
Hypercholesterolemia
Alcohol Drinking
Epidemiology
Cardiovascular Diseases
Therapeutics
Obesity
Smoking
Pharmacology
Pharmaceutical Preparations

Keywords

  • Antihypertensive treatment
  • Cardiovascular risk
  • Clinical trials
  • Drugs
  • Management guidelines

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{167de7a6e7c84dc8b9848816cd1287b8,
title = "World Health Organization - International Society of Hypertension Guidelines and the role of ongoing trials",
abstract = "Guidelines for non-pharmacological and pharmacological approaches to the treatment of hypertension were issued for the first time in the middle of the 1970s and were periodically updated in the following years. This paper will review the main features and elements of novelty of the World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension issued in 1999. After briefly describing data relating to the epidemiology of hypertension, the 1999 WHO-ISM Guidelines take into account the determinants of cardiovascular disease risk in hypertensive patients. Particular emphasis is placed on the contributions from and interactions between high blood pressure and other factors or conditions (diabetes, smoking, hypercholesterolaemia, alcohol consumption, overweight and obesity, etc) involved in determining the risk profile of individual patients. Finally, the WHO-ISM 1999 Guidelines provide recommendations for hypertension drug treatment in relation to the risk stratification and prognosis quantification, indicating the specific therapeutic strategy to be followed in each risk category.",
keywords = "Antihypertensive treatment, Cardiovascular risk, Clinical trials, Drugs, Management guidelines",
author = "G. Mancia and G. Grassi",
year = "2000",
language = "English",
volume = "2",
pages = "7--10",
journal = "European Heart Journal, Supplement",
issn = "1520-765X",
publisher = "Oxford University Press",
number = "D",

}

TY - JOUR

T1 - World Health Organization - International Society of Hypertension Guidelines and the role of ongoing trials

AU - Mancia, G.

AU - Grassi, G.

PY - 2000

Y1 - 2000

N2 - Guidelines for non-pharmacological and pharmacological approaches to the treatment of hypertension were issued for the first time in the middle of the 1970s and were periodically updated in the following years. This paper will review the main features and elements of novelty of the World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension issued in 1999. After briefly describing data relating to the epidemiology of hypertension, the 1999 WHO-ISM Guidelines take into account the determinants of cardiovascular disease risk in hypertensive patients. Particular emphasis is placed on the contributions from and interactions between high blood pressure and other factors or conditions (diabetes, smoking, hypercholesterolaemia, alcohol consumption, overweight and obesity, etc) involved in determining the risk profile of individual patients. Finally, the WHO-ISM 1999 Guidelines provide recommendations for hypertension drug treatment in relation to the risk stratification and prognosis quantification, indicating the specific therapeutic strategy to be followed in each risk category.

AB - Guidelines for non-pharmacological and pharmacological approaches to the treatment of hypertension were issued for the first time in the middle of the 1970s and were periodically updated in the following years. This paper will review the main features and elements of novelty of the World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension issued in 1999. After briefly describing data relating to the epidemiology of hypertension, the 1999 WHO-ISM Guidelines take into account the determinants of cardiovascular disease risk in hypertensive patients. Particular emphasis is placed on the contributions from and interactions between high blood pressure and other factors or conditions (diabetes, smoking, hypercholesterolaemia, alcohol consumption, overweight and obesity, etc) involved in determining the risk profile of individual patients. Finally, the WHO-ISM 1999 Guidelines provide recommendations for hypertension drug treatment in relation to the risk stratification and prognosis quantification, indicating the specific therapeutic strategy to be followed in each risk category.

KW - Antihypertensive treatment

KW - Cardiovascular risk

KW - Clinical trials

KW - Drugs

KW - Management guidelines

UR - http://www.scopus.com/inward/record.url?scp=0034010584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034010584&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0034010584

VL - 2

SP - 7

EP - 10

JO - European Heart Journal, Supplement

JF - European Heart Journal, Supplement

SN - 1520-765X

IS - D

ER -